BIOMAT Database Logo BIOMAT Database Logo

A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives. 1982

W Guy, and T A Ban, and J P McEvoy, and W M Petrie, and W H Wilson, and J D Schaffer

In a multicenter series of trials, viloxazine was compared with imipramine, amitriptyline, doxepin and placebo in 123 neurotic and endogenous depressive inpatients and outpatients. While significant period effects reflecting improvement were obtained on the majority of efficacy variables, no significant differences were obtained among the treatment groups or depressive types. Imipramine and amitriptyline exhibited more anticholinergic adverse reactions; while, viloxazine exhibited greater CNS effects. Dizziness and nausea were much more frequent in neurotic depressives which may be related to their psychopathology.

UI MeSH Term Description Entries
D007099 Imipramine The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. Imidobenzyle,Imizin,4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2),Imipramine Hydrochloride,Imipramine Monohydrochloride,Imipramine Pamoate,Janimine,Melipramine,Norchlorimipramine,Pryleugan,Tofranil
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004244 Dizziness An imprecise term which may refer to a sense of spatial disorientation, motion of the environment, or lightheadedness. Lightheadedness,Orthostasis,Dizzyness,Light-Headedness,Light Headedness
D004316 Doxepin A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors. Apo-Doxepin,Aponal,Deptran,Desidox,Doneurin,Doxepia,Doxepin Hydrochloride,Doxepin Hydrochloride, Cis-Trans Isomer Mixture (approximately 1:5),Doxepin beta,Doxepin-RPh,Espadox,Mareen,Novo-Doxepin,Prudoxin,Quitaxon,Sinequan,Sinquan,Xepin,Zonalon,Apo Doxepin,ApoDoxepin,Doxepin RPh,Hydrochloride, Doxepin,Novo Doxepin
D005260 Female Females

Related Publications

W Guy, and T A Ban, and J P McEvoy, and W M Petrie, and W H Wilson, and J D Schaffer
Parental representations of neurotic and endogenous depressives.
January 1987, Journal of affective disorders,
W Guy, and T A Ban, and J P McEvoy, and W M Petrie, and W H Wilson, and J D Schaffer
Childhood experiences of endogenous and neurotic depressives.
January 1985, European archives of psychiatry and neurological sciences,
W Guy, and T A Ban, and J P McEvoy, and W M Petrie, and W H Wilson, and J D Schaffer
Two dosages of imipramine in hospitalized endogenous and neurotic depressives.
September 1976, Archives of general psychiatry,
W Guy, and T A Ban, and J P McEvoy, and W M Petrie, and W H Wilson, and J D Schaffer
Levels of total and free tryptophan in the plasma of endogenous and neurotic depressives.
January 1981, Archiv fur Psychiatrie und Nervenkrankheiten,
W Guy, and T A Ban, and J P McEvoy, and W M Petrie, and W H Wilson, and J D Schaffer
A comparison of female and male neurotic depressives.
January 1976, Journal of clinical psychology,
W Guy, and T A Ban, and J P McEvoy, and W M Petrie, and W H Wilson, and J D Schaffer
Neurotic depressives' and alcoholics' oral Rorschach percepts.
December 1956, Journal of projective techniques,
W Guy, and T A Ban, and J P McEvoy, and W M Petrie, and W H Wilson, and J D Schaffer
Some differences between neurotic and psychotic depressives.
September 1972, The British journal of social and clinical psychology,
W Guy, and T A Ban, and J P McEvoy, and W M Petrie, and W H Wilson, and J D Schaffer
Viloxazine as a betamimetic antidepressant drug.
January 1987, Neuropsychobiology,
W Guy, and T A Ban, and J P McEvoy, and W M Petrie, and W H Wilson, and J D Schaffer
Social competence in schizopherenics, neurotic depressives and normals.
October 1987, Indian journal of psychiatry,
W Guy, and T A Ban, and J P McEvoy, and W M Petrie, and W H Wilson, and J D Schaffer
The endogenous--neurotic distinction as a predictor of response to antidepressant drugs.
February 1976, Psychological medicine,
Copied contents to your clipboard!